British Columbia's provincial government "has provided incredible leadership" in adopting the Treatment as Prevention strategy, says Montaner. He wants the provinces and the federal government to follow that example, pointing to the additional benefit of the money the health care system saves by averting new infections.
Despite yearly letters to Prime Minister Stephen Harper and successive federal health ministers requesting a meeting to discuss the BC approach and how to extend it across the country, Montaner says neither the Prime Minister's Office (PMO) nor the health minister has agreed to see him. In an Aug. 26 letter, a member of the PMO's correspondence staff wrote that Harper's "extremely demanding schedule" made it impossible for him to accommodate Montaner's meeting request. The letter then went to Health Minister Rona Ambrose's office, which has not responded.
In an emailed statement, the Public Health Agency of Canada appeared to cast doubt on the effectiveness of the BC approach, suggesting that because of BC's "very comprehensive approach to reducing the HIV epidemic … it is difficult to determine how much of the reduction can be attributed solely to the Treatment as Prevention Pilot at this time." "More evaluation is needed to determine the feasibility, long-term sustainability, safety and effectiveness of new prevention technologies such as Treatment as Prevention in Canada and globally," Stéphane Shank, a senior media advisor at Health Canada, wrote to CMAJ. "The [Public Health] Agency [of Canada] continues to monitor the results of pilot studies and randomized controlled trials. Further, the Agency is examining ways to facilitate other demonstration pilots to assess reproducibility of the BC findings." Despite a request from CMAJ, Health Canada did not comment on why neither the prime minister nor Ambrose has met with Montaner.
Meanwhile, Montaner has consulted with the White House, the UK parliament and China on how to bring Treatment as Prevention to their citizens, Montaner says. The World Health Organization has also recommended that countries adopt the strategy.
"What breaks my heart is that we know what needs to be done. It's a made-inCanada strategy," Montaner says. "It's been adopted around the world, and the federal government doesn't want to talk about it because of prejudice and discrimination against the population most affected."
Like many of those involved in the fight against HIV/AIDS, Montaner was disappointed that Canada has not yet announced a new contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria. Montaner is calling on Canada to match, on a GDP-adjusted, population-based framework, the contribution of the five highest contributors to the Global Fund.
